Drawing for SMRT

USPTO serial 79254733

SMRT

Reviewed by CopyMark Law Group

Reg. 6391648Status 700Renewal
Filing date
Status date
Registration date
Jun 22, 2021
Examiner
ADEMI, XHENETA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SMRT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $975

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew J. Stark

Matthew J. Stark Price Heneveld LLP695 Kenmoor Avenue SEGrand Rapids, MI 49501UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Stem cells for medical purposes for regeneration of bone and soft tissue; medical preparations for use in connection with the regeneration of bone and soft tissue; guided tissue regeneration materials, namely, medical preparations for use in connection with the regeneration of bone and soft tissue; biological preparations for medical purposes, namely, for the regeneration of bone and soft tissue; tissue-regenerative medical preparations, namely, for use in connection with the regeneration of bone and soft tissue; medical preparations in the nature of tissues for medical use, namely, for use in connection with the regeneration of bone and soft tissue; materials for dental treatment, namely, dental preparations for use in connection with the regeneration of dental tissue; materials for making dental restorations, namely, dental preparations for use in connection with the regeneration of dental tissue; dental repair materials, namely, dental preparations for use in connection with the regeneration of dental tissue; dental restorative materials, namely, dental preparations for use in connection with the regeneration of dental tissue; surgical implants, namely, living tissues grown from stem cells for use in connection with the regeneration of bone and soft tissue; collagen for medical use; medical preparations in the nature of biodegradable implants for use in guided tissue regeneration, namely, for use in connection with the regeneration of bone and soft tissue; medical preparations in the nature of implant materials for use in guided tissue regeneration in surgery, namely, for use in connection with the regeneration of bone and soft tissue; medical preparations in the nature of implantable materials for use in guided tissue regeneration, namely, for use in connection with the regeneration of bone and soft tissue; medical preparations in the nature of implants for guided tissue regeneration, namely, for use in connection with the regeneration of bone and soft tissue; therapeutic agents for medical purposes, namely, for the regeneration of bone and soft tissue; therapeutic biological tissue cultures for medical purposes, namely, for the regeneration of bone and soft tissue; none of the aforementioned goods being or in relation to genomics, sequencing of genomes, transcriptomes or epigenomes, medical diagnostic assays and reagents for use in genetic sequencing and biochemical analysisACTIVE—
042Scientific and technological research services in the field of biomechanical and cellular therapeutic medical techniques and design services, namely, design of new tissue and bone regeneration products and techniques related to biomechanical and cellular therapeutic techniquesACTIVE—
044Advisory services relating to medical services; physical therapy; medical services; medical advisory services; medical care services; medical health assessment services; medical treatment services for the regeneration of bone and soft tissue; provision of medical information; provision of medical services for the regeneration of bone and soft tissue; physical therapy services; all of the foregoing related to regeneration of bone and soft tissues and biomechanical and cellular therapeutic techniquesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 22, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 3, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 8, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 8, 2021FIMPFINAL DISPOSITION PROCESSED—
Sep 22, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 22, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 12, 2021GPNXNOTIFICATION PROCESSED BY IB—
Apr 6, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 6, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 17, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 17, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 17, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 4, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 4, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Mar 4, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 4, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 4, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 25, 2020OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 5, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 26, 2020OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 24, 2020LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Jul 15, 2020RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 29, 2020ALIEASSIGNED TO LIE—
Feb 18, 2020LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Feb 7, 2020LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Jan 31, 2020LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Dec 4, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 4, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Dec 4, 2019CNSLSUSPENSION LETTER WRITTEN—
Nov 1, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 1, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 1, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 25, 2019RFNTREFUSAL PROCESSED BY IB—
May 3, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 3, 2019RFRRREFUSAL PROCESSED BY MPU—
Apr 18, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 17, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 10, 2019DOCKASSIGNED TO EXAMINER—
Mar 30, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 26, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 21, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance